The β-Secretase BACE1 in Alzheimer's Disease.


Journal

Biological psychiatry
ISSN: 1873-2402
Titre abrégé: Biol Psychiatry
Pays: United States
ID NLM: 0213264

Informations de publication

Date de publication:
15 04 2021
Historique:
received: 08 08 2019
revised: 29 01 2020
accepted: 05 02 2020
pubmed: 1 4 2020
medline: 24 4 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

BACE1 (beta-site amyloid precursor protein cleaving enzyme 1) was initially cloned and characterized in 1999. It is required for the generation of all monomeric forms of amyloid-β (Aβ), including Aβ

Identifiants

pubmed: 32223911
pii: S0006-3223(20)30063-9
doi: 10.1016/j.biopsych.2020.02.001
pmc: PMC7533042
mid: NIHMS1631119
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
Amyloid beta-Protein Precursor 0
Bace2 protein, mouse 0
Amyloid Precursor Protein Secretases EC 3.4.-
Aspartic Acid Endopeptidases EC 3.4.23.-
BACE1 protein, human EC 3.4.23.46
Bace1 protein, mouse EC 3.4.23.46

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

745-756

Subventions

Organisme : Medical Research Council
ID : MR/L501542/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-0907
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701075
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS074256
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG046929
Pays : United States
Organisme : Medical Research Council
ID : MR/N026004/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0901254
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

J Neurosci. 2011 May 25;31(21):7775-83
pubmed: 21613490
J Alzheimers Dis. 2011;24 Suppl 2:53-9
pubmed: 21403391
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Arch Gen Psychiatry. 2007 Jun;64(6):718-26
pubmed: 17548753
Int J Clin Exp Pathol. 2015 Feb 01;8(2):1565-74
pubmed: 25973041
Neurobiol Aging. 2008 Jun;29(6):861-73
pubmed: 17331621
Brain Res Bull. 2012 Sep 1;88(6):596-601
pubmed: 22721728
Neuromolecular Med. 2012 Mar;14(1):65-73
pubmed: 22350541
Nat Neurosci. 2001 Sep;4(9):887-93
pubmed: 11528419
Alzheimers Dement. 2019 Jul;15(7):940-950
pubmed: 31113760
J Neurosci Res. 2012 Dec;90(12):2247-58
pubmed: 22987781
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):3954-3959
pubmed: 29581300
J Neurosci. 2014 Mar 12;34(11):3826-40
pubmed: 24623762
Biochem J. 2007 Nov 1;407(3):383-95
pubmed: 17425515
Acta Neuropathol. 2018 Dec;136(6):821-853
pubmed: 30488277
Science. 2002 Oct 25;298(5594):789-91
pubmed: 12399581
J Neurosci. 2008 Jan 30;28(5):1213-23
pubmed: 18234899
Brain. 2018 Apr 1;141(4):1186-1200
pubmed: 29462334
EMBO Mol Med. 2012 Sep;4(9):980-91
pubmed: 22903875
Acta Neuropathol. 2016 Aug;132(2):235-256
pubmed: 26993139
Alzheimers Res Ther. 2016 Oct 3;8(1):41
pubmed: 27716408
Nat Commun. 2019 Mar 22;10(1):1331
pubmed: 30902970
Life Sci Alliance. 2018 Feb 15;1(1):e201800026
pubmed: 30456346
N Engl J Med. 2018 May 3;378(18):1691-1703
pubmed: 29719179
Science. 1999 Oct 22;286(5440):735-41
pubmed: 10531052
J Alzheimers Dis. 2019;69(3):615-629
pubmed: 31156173
Acta Neuropathol. 2015 Jan;129(1):21-37
pubmed: 25432317
J Neurosci. 2007 Dec 12;27(50):13667-79
pubmed: 18077678
Biol Psychiatry. 2018 Mar 1;83(5):428-437
pubmed: 28129943
Nature. 2012 Aug 2;488(7409):96-9
pubmed: 22801501
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5585-90
pubmed: 18385378
Alzheimers Dement. 2014 Oct;10(5 Suppl):S425-S429.e1
pubmed: 24239250
Trends Neurosci. 2016 Mar;39(3):158-169
pubmed: 26833257
Science. 2014 May 30;344(6187):1023-8
pubmed: 24876496
Brain. 2019 Oct 1;142(10):3230-3242
pubmed: 31501889
Mol Neurodegener. 2016 Oct 5;11(1):67
pubmed: 27716410
Nat Neurosci. 2009 Dec;12(12):1567-76
pubmed: 19935655
Brain Res. 2011 Jun 13;1395:108-15
pubmed: 21565331
N Engl J Med. 2019 Apr 11;380(15):1483-1485
pubmed: 30970197
Science. 2009 Mar 13;323(5920):1473-7
pubmed: 19286555
Aging Cell. 2018 Feb;17(1):
pubmed: 29094448
Cell Mol Life Sci. 2017 Aug;74(15):2827-2838
pubmed: 28337562
J Alzheimers Dis. 2010;21(1):75-9
pubmed: 20413881
J Biol Chem. 2017 Feb 3;292(5):1679-1690
pubmed: 28028177
J Alzheimers Dis. 2011;25(2):373-81
pubmed: 21460439
Science. 1992 Apr 10;256(5054):184-5
pubmed: 1566067
Nat Neurosci. 2001 Mar;4(3):231-2
pubmed: 11224535
Neurobiol Aging. 2020 Apr;88:83-90
pubmed: 32087948
Prog Neurobiol. 2006 Jun;79(2):95-111
pubmed: 16904810
J Biol Chem. 2009 Feb 6;284(6):3793-803
pubmed: 19074428
J Biol Chem. 2005 Sep 2;280(35):30797-806
pubmed: 15987683
Prog Neurobiol. 2019 Oct;181:101662
pubmed: 31351912
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Nat Med. 2008 Aug;14(8):837-42
pubmed: 18568035
Neuron. 2007 Sep 6;55(5):697-711
pubmed: 17785178
Neuroscience. 2015 May 21;294:172-81
pubmed: 25779965
J Neurosci. 2009 Dec 16;29(50):15660-8
pubmed: 20016080
Sci Rep. 2019 Jul 3;9(1):9640
pubmed: 31270419
Sci Transl Med. 2018 Sep 19;10(459):
pubmed: 30232227
FASEB J. 2019 Mar;33(3):4404-4417
pubmed: 30576233
J Neurochem. 2014 Jul;130(1):4-28
pubmed: 24646365
Acta Neuropathol Commun. 2014 Mar 31;2:36
pubmed: 24684730
J Biol Chem. 2010 Jul 30;285(31):24108-19
pubmed: 20484053
Brain Res. 2010 Nov 29;1362:13-22
pubmed: 20875798
Neuroimage. 2010 May 15;51(1):280-7
pubmed: 20004726
Nature. 2015 Oct 15;526(7573):443-7
pubmed: 26322584
Clin Biochem. 2008 Aug;41(12):986-96
pubmed: 18489907
Nat Genet. 1992 Aug;1(5):345-7
pubmed: 1302033
J Mol Neurosci. 1995;6(2):141-6
pubmed: 8746452
Neuropharmacology. 1999 Mar;38(3):349-59
pubmed: 10219973
Prog Neurobiol. 2019 Apr;175:35-53
pubmed: 30593839
Nat Neurosci. 2017 Feb 23;20(3):353-364
pubmed: 28230844
Dement Geriatr Cogn Disord. 2018;45(3-4):152-161
pubmed: 29788013
PLoS One. 2016 Feb 03;11(2):e0147254
pubmed: 26840340
J Biol Chem. 2012 Dec 14;287(51):42867-80
pubmed: 23109336
J Biol Chem. 2012 Jul 27;287(31):25927-40
pubmed: 22692213
Neuroscience. 1999 Apr;90(1):1-13
pubmed: 10188929
J Biol Chem. 2000 Jul 14;275(28):21099-106
pubmed: 10887202
J Neurochem. 2016 May;137(3):436-45
pubmed: 26710318
J Alzheimers Dis. 2015;49(4):1095-103
pubmed: 26639974
Nat Rev Neurosci. 2016 Dec;17(12):777-792
pubmed: 27829687
J Alzheimers Dis. 2015;46(2):431-40
pubmed: 25790831
Biol Psychiatry. 2018 Oct 1;84(7):478-487
pubmed: 29945719
Neurology. 2012 Jul 17;79(3):229-36
pubmed: 22700814
Epigenetics Chromatin. 2018 Jul 25;11(1):41
pubmed: 30045751
Exp Brain Res. 2012 Apr;217(3-4):463-70
pubmed: 22094714
Neuroscience. 2012 Sep 18;220:256-66
pubmed: 22728099
Ann Neurol. 2008 Mar;63(3):377-87
pubmed: 18300294
J Biol Chem. 2009 Jan 23;284(4):1971-81
pubmed: 18986979
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6415-20
pubmed: 18434550
BMC Med Genet. 2012 May 17;13:35
pubmed: 22594617
PLoS One. 2015 Dec 17;10(12):e0145695
pubmed: 26678744
Neurochem Res. 2013 Jul;38(7):1415-23
pubmed: 23575575
Cell. 2014 Nov 6;159(4):721-6
pubmed: 25417150
J Neurosci Res. 2009 Feb;87(2):360-8
pubmed: 18798280
Transl Psychiatry. 2017 Aug 1;7(8):e1190
pubmed: 28763060
JAMA Neurol. 2019 Jun 3;:
pubmed: 31157827
Biochemistry. 2002 Jul 9;41(27):8742-6
pubmed: 12093293
J Biol Chem. 2001 Jun 29;276(26):23322-8
pubmed: 11316808
EMBO J. 2012 Jun 22;31(14):3157-68
pubmed: 22728825
IUBMB Life. 2012 Dec;64(12):943-50
pubmed: 23180460
Alzheimers Dement. 2018 Jul;14(7):869-879
pubmed: 29580670
Brain. 2008 May;131(Pt 5):1252-8
pubmed: 18334538
Toxicol Lett. 2012 Feb 25;209(1):94-105
pubmed: 22178568
J Neurosci. 2007 Apr 4;27(14):3639-49
pubmed: 17409228
Nat Commun. 2019 May 21;10(1):2246
pubmed: 31113950
Arch Neurol. 2008 Aug;65(8):1102-7
pubmed: 18695061
Am J Pathol. 2012 Jan;180(1):337-50
pubmed: 22074738
J Prev Alzheimers Dis. 2019;6(2):78-84
pubmed: 30756113
Int J Biochem Mol Biol. 2012;3(4):365-73
pubmed: 23301201
J Neurosci. 2010 Oct 27;30(43):14411-9
pubmed: 20980598
Brain Res Mol Brain Res. 1995 Aug;32(1):36-44
pubmed: 7494461
Arch Neurol. 2011 Sep;68(9):1107-8
pubmed: 21911693
J Neurosci. 2007 Jul 18;27(29):7817-26
pubmed: 17634375
Nature. 1992 Sep 24;359(6393):322-5
pubmed: 1383826
J Neurosci. 2014 Oct 1;34(40):13314-25
pubmed: 25274811
Cell Metab. 2011 Sep 7;14(3):365-77
pubmed: 21907142
Alzheimers Dement. 2019 Oct;15(10):1274-1285
pubmed: 31627825
J Biol Chem. 2001 May 18;276(20):16739-48
pubmed: 11278492
Biol Psychiatry. 2018 Mar 1;83(5):447-455
pubmed: 28359566
J Biol Chem. 2014 Feb 21;289(8):5184-98
pubmed: 24352696
J Biol Chem. 2009 Mar 27;284(13):8495-506
pubmed: 19164281
Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712
pubmed: 21852788
Genes Dev. 1988 Sep;2(9):1127-35
pubmed: 3056778
Science. 2006 Oct 27;314(5799):664-6
pubmed: 16990514
J Biol Chem. 2001 May 4;276(18):14634-41
pubmed: 11278841
Acta Neuropathol. 2013 Sep;126(3):329-52
pubmed: 23820808
J Neurochem. 2003 Mar;84(5):1006-17
pubmed: 12603825
J Alzheimers Dis. 2014;40(4):981-92
pubmed: 24531160
Science. 2019 Jan 11;363(6423):
pubmed: 30630900
Mol Cell Neurosci. 2002 Feb;19(2):175-85
pubmed: 11860271
EMBO Mol Med. 2015 Jan 15;7(2):175-89
pubmed: 25592972
CNS Drugs. 2019 Mar;33(3):251-263
pubmed: 30830576
PLoS One. 2015 Aug 28;10(8):e0136950
pubmed: 26317805
Mol Cell Neurosci. 2003 Nov;24(3):646-55
pubmed: 14664815
Ann Neurol. 2017 Jul;82(1):128-132
pubmed: 28556232
PLoS One. 2014 Jul 22;9(7):e103067
pubmed: 25051175
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10658-63
pubmed: 23754390
J Alzheimers Dis. 2010;20(1):253-60
pubmed: 20164582
Hum Mol Genet. 2001 Jun 1;10(12):1317-24
pubmed: 11406613
Prog Neurobiol. 2003 May;70(1):1-32
pubmed: 12927332

Auteurs

Harald Hampel (H)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: harald_hampel@eisai.com.

Robert Vassar (R)

Department of Neurology, Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Bart De Strooper (B)

Department of Neurosciences, KU Leuven, Leuven, Belgium; Centre for Brain and Disease Research, VIB (Flanders Institute for Biotechnology), Leuven, Belgium; Dementia Research Institute, University College London, London, United Kingdom.

John Hardy (J)

Department of Molecular Neuroscience and Reta Lilla Weston Laboratories, Queen Square Institute of Neurology, University College London, London, United Kingdom.

Michael Willem (M)

Chair of Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig Maximilians University Munich, Munich, Germany.

Neeraj Singh (N)

Department of Neuroscience, University of Connecticut Health, Farmington, Connecticut.

John Zhou (J)

Department of Neuroscience, University of Connecticut Health, Farmington, Connecticut.

Riqiang Yan (R)

Department of Neuroscience, University of Connecticut Health, Farmington, Connecticut.

Eugeen Vanmechelen (E)

ADx NeuroSciences NV, Ghent, Belgium.

Ann De Vos (A)

ADx NeuroSciences NV, Ghent, Belgium.

Robert Nisticò (R)

Laboratory of Neuropharmacology, EBRI Rita Levi-Montalcini Foundation, Rome, Italy; School of Pharmacy, Department of Biology, University of Rome "Tor Vergata," Rome, Italy.

Massimo Corbo (M)

Department of Neurorehabilitation Sciences, Casa Cura Policlinico, Milan, Italy.

Bruno Pietro Imbimbo (BP)

Department of Research and Development, Chiesi Farmaceutici, Parma, Italy.

Johannes Streffer (J)

Reference Center for Biological Markers of Dementia, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; UCB Biopharma SPRL, Braine-l'Alleud, Belgium.

Iryna Voytyuk (I)

Department of Neurosciences, KU Leuven, Leuven, Belgium; Centre for Brain and Disease Research, VIB (Flanders Institute for Biotechnology), Leuven, Belgium; ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge, United Kingdom.

Maarten Timmers (M)

Reference Center for Biological Markers of Dementia, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; Janssen Research and Development, a division of Janssen Pharmaceutica, Beerse, Belgium.

Amir Abbas Tahami Monfared (AA)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

Michael Irizarry (M)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.

Bruce Albala (B)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.

Akihiko Koyama (A)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.

Naoto Watanabe (N)

Eisai Company Ltd., Tokyo, Japan.

Teiji Kimura (T)

Eisai Company Ltd., Tokyo, Japan.

Lisa Yarenis (L)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.

Simone Lista (S)

Sorbonne University, GRC No. 21, Alzheimer Precision Medicine, Pitié-Salpêtrière Hospital, Paris, France; Institute of Memory and Alzheimer's Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France; Brain & Spine Institute, INSERM U 1127, CNRS UMR 7225, Paris, France.

Lynn Kramer (L)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.

Andrea Vergallo (A)

Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine, Pitié-Salpêtrière Hospital, Paris, France; Institute of Memory and Alzheimer's Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France; Brain & Spine Institute, INSERM U 1127, CNRS UMR 7225, Paris, France. Electronic address: andrea_vergallo@eisai.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH